NCT01648790 - A Study of Prasugrel in Healthy Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Healthy Volunteers

Interventions

DRUG

Prasugrel ODT1 - Tablet

Administered orally as tablet.

DRUG

Prasugrel ODT2 - Tablet

Administered orally as tablet.

DRUG

Prasugrel ODT2 - Suspension

Administered orally as suspension.

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas